Categories
Health

What Are The Roadblocks to a Covid Vaccine Passport?

With all American adults now eligible for Covid-19 vaccines and with businesses and international borders reopening, a heated debate has begun in the United States over whether a digital health certificate (often and somewhat misleadingly called a “vaccine passport”) will be required should to prove vaccination status.

Currently, Americans are being issued a white paper card as evidence of their Covid-19 shots, which can be easily forged, and online scammers are already selling fake and stolen vaccination cards.

While the federal government has announced that it will not introduce federal mandate digital vaccination records, a growing number of companies – from cruise ships to sports venues – are saying that they need proof of vaccination for entry or services. Hundreds of digital health passport initiatives are struggling to bring apps to market that provide a verified electronic record of vaccinations and negative Covid-19 test results to streamline the process.

The initiative has raised privacy and equity concerns, and some states like Florida and Texas have banned companies from requiring vaccination certificates. However, the developers argue that the digital infrastructure is secure and will help expedite the process of reopening society and revitalizing travel.

Governments, tech companies, airlines and other companies are testing different versions of the digital health passports and trying to develop common standards so that each system is compatible and health records can be created in a secure and controlled format.

The process is associated with major technical challenges, especially due to the large number of ongoing app initiatives. For the certificates to be useful, countries, airlines and companies must agree on common standards and the infrastructure they use must be compatible. In the United States, getting individual states to share vaccination data with different certificate platforms while preserving the privacy of residents is also complicated.

Here’s what we know about the current state of digital health passports and some of the obstacles they face in the United States.

In March, New York became the first state in the United States to introduce a digital health certificate called the Excelsior Pass, which checks a person’s negative coronavirus test result and whether they are fully vaccinated.

The app and website, which have now been downloaded more than a million times, are free and voluntary for all New Yorkers, and offer a QR code that can be scanned or printed out to check a person’s health records. The pass has been used by thousands of New Yorkers to enter Yankee Stadium, Madison Square Garden, and other smaller public venues.

Most companies require individuals to present their government ID along with their Excelsior passport to prevent possible fraud.

In Israel, where more than half of the population is fully vaccinated, residents are required to show an electronic “Green Pass” to visit places such as gyms, concerts, wedding halls and dine indoors.

The European Union has approved an electronic vaccination certificate, due to be recognized from July 1, that a number of European countries have already used, but each individual member country can set its own rules for travel requirements. The UK has also started testing a Covid-19 certificate system designed to help companies reopen safely.

Some airlines, including Lufthansa, Virgin Atlantic and Jet Blue, have started using the Common Pass digital health app to check passengers’ Covid-19 test results before boarding. The International Air Transport Association’s Health Pass is used by more than 20 airlines and allows passengers to upload health certificates required for international travel.

That depends on the state regulations. The Biden government has announced that there will be no federal immunization system or mandate. Individual states have primary public health powers in the United States and have the power to request vaccines.

Let us help you protect your digital life

“We assume that a vaccine pass, or whatever you want to call it, is being driven by the private sector,” White House press secretary Jen Psaki said at a briefing in March. “There will be no centralized, universal federal vaccination database and no federal mandate that prescribes a single vaccination card for everyone.”

In April, Texas Governor Greg Abbott issued an executive order banning government agencies, private companies, and institutions receiving state funding from requiring individuals to prove they had been vaccinated against the coronavirus.

Florida Governor Ron DeSantis issued a similar order, saying that demonstrating vaccination would “limit individual freedom” and “harm patient privacy” as well as “create two classes of citizens based on vaccinations.”

But these orders cannot be held liable. “The governors are on uncertain legal ground,” said Lawrence Gostin, director of the O’Neill Institute for National and Global Health Law at Georgetown University. “Of course, lawmakers have the power to regulate businesses in the state, and they can stop counties and local governments from issuing vaccine passports. But a governor who acts alone has no inherent power to regulate businesses except through emergency or other health powers given to them by law. “

There is no centralized federal vaccine database in the United States. Instead, states collect this information. All states except New Hampshire have their own vaccination registers, and some cities, like New York, have their own.

Currently, states are required to share their registers with the Centers for Disease Control and Prevention, but the data is not public and could be withheld.

That means anyone developing a digital vaccination certificate in the United States will need to obtain vaccination records from individual states, which could be problematic in states that oppose health passport initiatives.

One of the problems is the terminology. A passport is issued by a government and certifies personal information, including an individual’s legal name and date of birth. Many people fear that they are giving out personal and sensitive health information to private companies that could be stolen or used for other purposes.

“There are many legitimate concerns about how privacy and technology would work with these systems, especially since Silicon Valley doesn’t have a great history in providing privacy enhancing technology,” said Brian Behlendorf, executive director of the Linux Foundation Public Health. an open source, technology oriented organization.

“And the concept of privacy here is complicated because, ultimately, you are trying to prove to someone that you received something,” he said. “You don’t keep a secret, so the challenge is to come up with something and prove it without forever creating a traceability chain that could be used.”

The Linux Foundation works with a network of technology companies called the Covid-19 Credentials Initiative to develop a set of privacy standards when using vaccine certificates. The main goal of the initiative is to create a verifiable ID (similar to a card in a wallet) that contains a range of information about a person, but is digitally native and cryptographically secure.

Some argue that such an ID would encroach on personal freedoms and private health decisions.

“‘Vaccine passports’ must stop,” former Texas representative Ron Paul wrote in a tweet last week. “To accept them is to accept the misconception that the government owns your life, your body and your freedom.”

Others fear that an all-digital system would leave some communities behind, especially those with no access to smartphones or the internet.

“All solutions in this area should be simple, free, open source, accessible to people both digitally and on paper, and designed from the start to protect people’s privacy,” said Jeff Zients, the coronavirus coordinator of the White House, in a statement.

The World Health Organization said in April that it does not yet support the need for vaccination certificates for travel due to uncertainty about whether vaccination will prevent transmission of the virus and equity concerns. But the organization is working with a number of agencies such as UNICEF, ITU and the European Commission to set the standards and specifications for a possible globally recognized digital vaccination card.

Follow the New York Times Travel on Instagram, Twitter and Facebook. And sign up for our weekly Travel Dispatch newsletter for expert tips on smarter travel and inspiration for your next vacation. Are you dreaming of a future short vacation or just traveling in an armchair? Check out our 52 places list for 2021.

Categories
Health

WHO says Covid is spreading quicker than the worldwide distribution of vaccines

Funeral directors wearing personal protective equipment carry a coffin during the funeral of a COVID-19 victim amid a coronavirus disease (COVID-19) nationwide lockdown at Olifantsvlei Cemetery, southwest of Joburg, South Africa, Jan. 6, 2021.

Siphiwe Sibeko | Reuters

The global spread of Covid-19 is advancing faster than the global distribution of vaccines, World Health Organization officials said on Monday.

They attributed transmission rates to new variants like Alpha and Delta, which have proven to be more contagious.

“This means that the risks for people who are not protected, ie most of the world’s population, have increased,” WHO Director General Tedros Adhanom Ghebreyesus said during a press conference.

While the number of new cases of the virus continues to decline worldwide, the number of deaths has not decreased by the same amount, he said. Since the pandemic began, more than 3.8 million people have died of Covid worldwide.

A person receives a dose of Pfizer BioNTech vaccine at a vaccination center for people over 18 years old at the Belmont Health Center in Harrow amid the coronavirus disease (COVID-19) outbreak in London, Great Britain, June 6, 2021.

Henry Nicholls | Reuters

The number of new cases has declined for seven straight weeks, the longest decline in the world since the pandemic began. But the number of deaths reported this week is still similar to last week, he said.

“While weekly cases are at their lowest level since February, deaths are not falling anytime soon,” Tedros said. “The global decline hides worrying increases in cases and deaths in many countries.”

Countries in Africa have higher Covid death rates than other countries, he said. The higher death rates are particularly worrying as African countries have reported fewer cases than most other regions.

African countries also have the least access to vaccines, diagnostics and oxygen supplies, underscoring the impact of medical inequality that global health authorities have warned about.

“There are enough vaccine doses around the world to contain transmission and save many lives when used in the right places for the right people,” said Tedros.

The G-7 have pledged to distribute 870 million doses of vaccine around the world, but WHO says more are needed.

“This is a big help, but we need more and we need it faster. More than 10,000 people die every day,” said Tedros.

Categories
Health

Novavax says its Covid vaccine is 90% efficient, plans FDA submission in Q3

A woman holds a small bottle with a sticker “Coronavirus COVID-19 Vaccine” and a medical syringe in front of the Novavax logo displayed in this image dated October 30, 2020.

Given Ruvic | Reuters

Biotech company Novavax said Monday its Covid-19 vaccine had been shown to be safe and 90.4% overall effective in a Phase III clinical trial involving nearly 30,000 participants in the United States and Mexico.

In addition, the two-dose vaccine was found to be 100% effective in preventing moderate and severe illness, and 93% effective in some variants. The company plans to file a regulatory filing with the Food and Drug Administration in the third quarter.

The late-stage study “confirms that NVX-CoV2373 has an encouraging tolerability and safety profile,” said Dr. Gregory Glenn, President of Research and Development at Novavax, in a press release. “These data show consistent, high efficacy and reaffirm the vaccine’s ability to prevent COVID-19 amid the virus’ s ongoing genetic evolution.”

With an abundance of vaccines already available in the US, it is possible that the government could donate the Novavax doses to other countries.

The company’s analysis evaluated 77 confirmed Covid infections among the 29,960 participants in the study. Novavax said 63 cases of Covid were seen in the placebo group, up from 14 cases seen in the group that received their two-dose vaccine. That resulted in an estimated vaccine effectiveness of 90.4%, it said.

The vaccine also appeared to be well tolerated, the company said. The most common side effects were fatigue, headache, muscle aches and pain at the injection site, which usually didn’t last more than two or three days, the company said.

All Covid hospital admissions in the study were in the placebo group, the company said.

Novavax said the vaccine appears to be effective against a few variants, including the alpha variant, which was first identified in the UK. About 65% of the cases where sequence data were available were of worrying variants, the company said.

If Novavax’s vaccine is FDA approved, it would follow three Covid-19 vaccines already approved in the U.S. by Pfizer-BioNTech, Moderna, and Johnson & Johnson for emergency use.

The new data comes as federal officials say the U.S. has more than enough doses of Covid vaccine to vaccinate the entire American population. According to the Centers for Disease Control and Prevention, more than 173 million Americans had received at least one dose of a Covid-19 vaccine as of Sunday.

The Biden government has already committed to donating at least 20 million doses of Covid vaccines from Pfizer-BioNTech, Moderna and J&J, and 60 million doses of AstraZeneca’s vaccine, which is not yet approved for use in the United States

Earlier this month, the White House announced it was lifting restrictions under the Defense Production Act, which gives the US priority to vaccines developed by AstraZeneca, Sanofi and Novavax.

Novavax said Monday it is still on track to hit production capacity of 100 million cans per month by the end of the third quarter and 150 million cans per month by the fourth quarter of 2021.

Categories
Health

contemporary calls to analyze the origins of covid

U.S. President Joe Biden speaks during a meeting with a bipartisan group of members of Congress.

Pool | Getty Images News | Getty Images

LONDON — The European Union and the United States are expected to call for more progress on an investigation into the origins of Covid-19, according to a draft EU document.

The draft document, seen by CNBC, is the foundation for the outcome of an upcoming summit between U.S. President Joe Biden and European leaders which is due on Tuesday. Its wording could change right up until the end of the meeting. 

Speaking Thursday, European Council President Charles Michel, who chairs European summits, said: “The world has the right to know exactly what happened, in order to be able to learn the lessons.”

We have to know where it did come from.

Ursula von der Leyen

European Commission president

At the same news conference on Thursday, European Commission President Ursula von der Leyen said: “It is of utmost importance that we learn about the origin of the coronavirus.”

“There is this horrible pandemic, a global pandemic we have to know where it did come from in order to draw the right lessons and to develop the right tools to make sure that this will never happen again and, therefore, the investigators need complete access to whatever is necessary to really find the source of this pandemic,” she added.

These statements follow Biden’s call last month for the World Health Organization to carry out a second phase of a probe into the origins of the virus, which was first detected in the Chinese city of Wuhan in late 2019.

A WHO report said earlier this year that the most likely cause of the virus was natural, and dismissed a lab leak theory. But it suggested that further studies would need to be carried out.

The U.S. intelligence community said last month that it “does not know exactly where, when, or how the Covid-19 virus was transmitted initially but has coalesced around two likely scenarios: either it emerged naturally from human contact with infected animals or it was a laboratory accident.”

The discussion on the origins of the coronavirus comes at a time when the U.S. and the EU also intend to talk about their broader relationship with China.

While on the one hand, the U.S. and the EU want to criticize what they describe as human rights violations in China; on the other hand, they want Beijing to engage constructively on climate change policies and to open up certain parts of its economy.

Biden is hoping that the EU will be a partner when it deals with China over the coming years.

“Biden believes that with a broad coalition, you may be able to push China down a more constructive path. International pressure, that is pressure not coming from Washington only, could prove useful on any of these topics,” Jeremy Ghez, associate professor at H.E.C. Business School in Paris, told CNBC last week.

The EU decided in March to put on hold the ratification of an investment agreement with Beijing — a deal that had been presented back in December, just weeks before the inauguration of Biden.

This investment partnership is now frozen following a diplomatic row between Brussels and Beijing. In March, the EU decided to impose sanctions against China for its treatment of the ethnic minority Uyghurs and Beijing retaliated by announcing counter-sanctions against members of the European Parliament.

The ethnic Uyghurs, who live mostly in China’s west, have been identified by the United Nations, United States, United Kingdom and others as a repressed group. China’s Foreign Ministry in March characterized such claims as “malicious lies” designed to “smear China” and “frustrate China’s development.”

Categories
Health

Dr. Scott Gottlieb on uncommon coronary heart irritation in younger Covid vaccine recipients

Rare instances of heart inflammation in young people after receiving their second Covid vaccine dose require further inquiry, Dr. Scott Gottlieb told CNBC on Friday.

However, the former Food and Drug Administration commissioner said the cases have mostly been mild and should not dissuade people from signing up for the two-shot regimens from Pfizer and Moderna.

“At this point, the risk/benefit still favors vaccination certainly in this age group,” Gottlieb, a Pfizer board member, said in an interview on “Squawk Box.” “That’s what CDC and FDA have also affirmed.”

A day earlier, the Centers for Disease Control and Prevention indicated it has seen a higher-than-projected number of cases of heart inflammation in 16-to-24-year-olds following their second Covid shot—  275 recorded occurrences compared with expectations of 10 to 102.

In people age 30 and below, there’s been 475 total reports of myocarditis or pericarditis, which according to the CDC involves inflammation of the heart muscle or the lining around it. Men make up the vast majority of reported instances of post-vaccine myocarditis or pericarditis.

Of the 270 people who developed the conditions and have been discharged from the hospital, 81% have fully recovered, according to CDC data. The remaining 19% either still have symptoms or their status is not known. Fifteen people are still hospitalized, the CDC said.

Symptoms, which include chest pain and shortness of breath, typically develop when a few days of receiving the vaccine, according to the CDC.

Gottlieb said many questions remain about the connection between the heart inflammation and the Covid vaccines from Pfizer and Moderna.

“I think at this point you need to assume there’s a causal relationship between the vaccine and these observations until you can prove otherwise,” said Gottlieb, who led the FDA from 2017 to 2019 in the Trump administration.

Gottlieb said what’s not known yet is whether there’s something specific about the vaccines that are causing heart inflammation. “We know the vaccine induces inflammatory response. That’s why you get a fever. That’s why you get injection-site pain because your immune system is stimulated.”

“Is this a more generalized inflammatory response from the vaccine that’s localizing in the heart in some patients?” Gottlieb asked. “Or is this something that’s more direct, where the vaccine itself is triggering some kind of very targeted immune reaction and it’s manifesting in this way? We don’t have the answers to these questions.”

It’s possible additional cases haven’t been recorded, Gottlieb said, but “we are probably capturing most of the severe cases.” He added, “When you look at the number of people who are having severe cases of pericarditis, it’s very small numbers right now.”

Roughly 141.5 million people in the U.S. have been fully vaccinated against Covid, according to CDC data. The vaccines have been critical in driving down the number of coronavirus cases in the U.S. to their lowest levels since early in the pandemic.

Categories
Health

Experiences of Extreme Covid or Demise After Vaccination Are Uncommon, however Not Surprising

In the past few months, a constant headline hit has highlighted the amazing effectiveness of Covid-19 vaccines in the field, particularly mRNA vaccines from Pfizer-BioNTech and Moderna. Studies have shown that the vaccines are more than 90 percent effective in preventing the worst outcomes, including hospitalization and death.

But alongside this good news, there have been rare reports of severe Covid in fully vaccinated people.

For example, on June 3, Napa County announced that a fully vaccinated woman who was more than a month after her second Moderna vaccination had died after being hospitalized with Covid. The over 65-year-old woman with previous illnesses had tested positive for the alpha variant identified for the first time in Great Britain.

While these cases are tragic, they are unusual – and not unexpected.

“I am very sad that she had such a serious illness that she actually died,” said Dr. William Schaffner, medical director of the National Foundation for Infectious Diseases and vaccines expert at Vanderbilt University. But, he noted, “we expected the occasional breakthrough infection to occur.”

Such cases shouldn’t prevent people from getting vaccinated, scientists said. “There is no vaccine in history that has ever been 100 percent effective,” said Dr. Paul Offit, the director of the Vaccine Education Center at the Children’s Hospital of Philadelphia. “This is your best chance to avoid serious, critical illness. But as with everything in medicine, it is not perfect. “

Severe Covid is rare in fully vaccinated people. In a paper released last month, the Centers for Disease Control and Prevention said they had received reports of 10,262 breakthrough infections as of April 30. That’s only a tiny fraction of the 101 million Americans who have been vaccinated to that date, though the agency noted that these are likely to be a “significant minority” of breakthrough infections.

Of these groundbreaking cases, 10 percent of patients were hospitalized and 2 percent died – and in some of those cases, patients were hospitalized or died of something unrelated to Covid-19. The average age of the deceased was 82 years.

Updated

June 11, 2021, 2:36 p.m. ET

Older adults, who are at higher risk of Covid complications, are also more likely to develop breakthrough infections as they are known to build weaker immune responses to vaccines. People with compromised immune systems or other chronic health conditions may also be at increased risk.

Some of the variants – especially Beta, which was first identified in South Africa – may be more likely to evade vaccine-induced protection. But beta isn’t common in the United States right now, noted Dr. Conductor.

The alpha variant that infected the Napa County woman is highly contagious, but vaccines offer good protection against it – as well as against the original strain of the virus.

“Breakthrough infection stories, while exceptionally rare, can be confusing to the public,” said Dr. Napa County’s health officer Karen Relucio in an email. “We know that with stories like this one could be tempted to question the effectiveness of vaccines.”

But the vaccines are highly effective, she stressed. In Napa County, the breakthrough infection rate in fully vaccinated people is just 0.04 percent, she said.

Nationwide, the rate is even lower. According to the California Department of Health, there were 5,723 breakthrough cases in more than 17.5 million fully vaccinated residents as of June 2, a rate of 0.032 percent. Of these cases, only 7 percent are known to have been hospitalized and 0.8 percent to have died. In these cases, too, it is unclear whether Covid was the main cause of death.

Breakthrough infections are likely to decline as more people are vaccinated and community transmission rates decline. “The virus will find fewer and fewer people to become infected – it will be more difficult for the virus to get through the population,” said Dr. Conductor. “These are great vaccines. So that the vaccines work optimally – individually and collectively – as many people as possible must be vaccinated. “

Categories
Health

The FDA reportedly forces J&J to scrap about 60 million doses of its Covid vaccine

A detail of the Janssen Johnson & Johnson COVID-19 vaccine that is not currently being issued because it has been put on hold.

Allen J. Cockroaches | Los Angeles Times | Getty Images

Federal regulators are forcing Johnson & Johnson to scrap approximately 60 million doses of the Covid-19 vaccine made at a troubled Baltimore facility operated by Emergent BioSolutions due to possible contamination, the New York Times reported on Friday, citing with people familiar with the matter.

The facility closed in April after an inspection revealed several violations, including possible contamination of J & J’s vaccines with a key ingredient from AstraZeneca’s Covid vaccine. About 170 million doses of both vaccines were eligible after the inspection, the Times reported.

The FDA confirmed to CNBC that several lots were not “suitable for use” without confirming the exact number of doses discarded. According to an email statement, the agency announced that it is releasing two batches of vaccine materials made at the facility for use. The Associated Press reported that the two batches would make 10 million cans.

“The FDA has determined that several other lots are unsuitable for use, but additional lots are still being tested and the agency will inform the public of the completion of these tests,” said a statement sent via email.

The US currently has more than enough doses of two other vaccines approved by Pfizer and Moderna to complete vaccination of the American population.

Approximately 10 million doses of the Johnson & Johnson vaccine continue to be distributed in the United States and donated to other countries. The rescued cans will come with a warning stating that federal regulators cannot guarantee that the manufacturing facility operator, Emergent BioSolutions, is following good manufacturing practices, the Times reported.

“Before making this decision, the FDA conducted a thorough review of the facility records and the results of the manufacturer’s quality checks,” the agency said. “Although the FDA is not yet ready to include the Emergent BioSolutions facility in the Janssen EUA as an authorized manufacturing facility, the agency continues to address issues with Janssen and the management of Emergent BioSolutions.”

The Biden government planned to donate more cans of the shots, but those plans were stifled by the investigation of the emergent facility.

The World Health Organization said it would take 11 billion doses worldwide to stop the pandemic from getting worse. The US is buying 500 million doses of Pfizer’s two-shot vaccine to be distributed to countries in need, President Joe Biden is expected to announce at G-7 meetings this weekend.

– CNBC’s Berkeley Lovelace Jr. contributed to this article.

Categories
World News

G-7 leaders to pledge 1 billion doses of Covid vaccines to poorer nations

LONDON – The G-7 leaders are expected to pledge 1 billion doses of coronavirus vaccine to poorer nations this weekend to allay concerns about vaccine nationalism.

The world’s most advanced economies – as the G-7 defines itself – have been criticized for not sharing more vaccines with countries that have fewer resources. For example, the United States has a legal requirement that it cannot send vaccines abroad until it has reached satisfactory levels of vaccination within its borders. The UK and the EU have also received similar criticism.

However, the G-7 countries – the US, UK, Canada, France, Germany, Italy and Japan – want to end the pandemic next year and will increase their individual contributions, according to a statement released by the UK government on Thursday.

The UK already announced on Thursday that it would donate at least 100 million surplus coronavirus vaccine doses within the next year. The United States also announced earlier this week that it would donate 500 million doses of the Pfizer BioNTech shot to low-income countries.

On Thursday, EU Commission President Ursula von der Leyen, who will represent the EU in the G-7, also said: “We are signing the G-7’s goal of ending the pandemic by 2022 through increased global vaccination.”

Sharing vaccines is described by health officials as the only way to end the pandemic completely. Because as long as the virus exists, it can mutate and spread around the world. At the same time, measures like lockdowns and social distancing are likely to continue to affect global economic performance.

According to the Johns Hopkins University, there have been more than 174 million cases of Covid-19 and more than 3.7 million deaths worldwide since the pandemic broke out in early 2020.

The pandemic is at the center of discussions among G-7 leaders, whose three-day summit in Cornwall, England, kicks off on Friday.

In this context, the US surprised other heads of state and government last month by supporting the waiver of intellectual property rights for Covid vaccines.

Health experts, human rights groups and international medical charities argue that this is vital to urgently addressing the global vaccine shortage amid the pandemic and ultimately avoiding a prolongation of the health crisis. However, vaccine makers say this could disrupt the flow of raw materials and result in less investment in health research by smaller biotech innovators.

This opinion is also shared by some EU leaders, in particular French President Emmanuel Macron and German Chancellor Angela Merkel.

Categories
Health

High FDA advisor says children should be vaccinated towards Covid

U.S. Senator Bob Casey, right, watches as Dr. Paul Offit speaks during a press conference in Philadelphia on Friday, Feb. 13, 2015.

Matt Rourke | AP

Children need to be vaccinated against Covid-19, a top advisor to the Food and Drug Administration’s childhood vaccines told the agency on Thursday.

“It just seems silly to think that we don’t need to involve children,” said Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia and advisor to the FDA. “They can suffer and be hospitalized and occasionally die.”

He said 300 children had died of Covid so far.

Offit, a voting member of the Agency’s Vaccines and Related Biological Products Advisory Committee, spoke about the use of Covid-19 vaccines in children 6 months of age during the panel’s meeting.

“We have variants that are becoming more contagious, which means you need higher population immunity … for years, if not decades,” Offit said. He also said that we vaccinate children against polio every year, although we haven’t had a polio case since the 1970s.

Data from the American Academy of Pediatrics shows that nearly 4 million children have tested positive for Covid since the pandemic began. In the past week, the data said more than 16,000 new cases in children were reported, the lowest since June 2020. In states reported, less than 1% of all Covid cases in children resulted in death, the AAP wrote their website.

“I think in winter we will really see how well we do on population immunity,” Offit said. “I think the idea that we will no longer have to vaccinate children in the future is wrong.”

Categories
Health

Bitcoin 2021 attendees report Covid instances after coming back from Miami

Some of the 12,000 attendees who flew to Miami for the largest Bitcoin event in history last weekend have started testing positive for Covid.

Bitcoin 2021 attracted crypto enthusiasts from around the world to the Mana Wynwood Convention Center in the arts and entertainment district of Miami. For three days, conference attendees huddled in overcrowded lecture halls, happy and hugging. It was the first major conference since the pandemic began, and many attendees said they were relieved to be among colleagues sharing messages and updates.

There was no mask requirement and no proof of compulsory vaccination for participation. Covid was just a topic of conversation in connection with everyone’s excitement about being on the other side of the pandemic.

This is of course until some conference participants said on Twitter that they had tested positive for the corona virus.

For full disclosure, I attended the show after receiving two doses of the Moderna vaccine this spring. Vaccination isn’t a 100% guarantee of immunity, but at the moment I have no symptoms. A lot of my conversations with Uber and Lyft drivers started with a discussion about vaccination together.

It remains to be seen whether the conference will ultimately be billed as a super spreader event.

It is unclear how many people are affected and whether the city of Miami had a contingency plan for such an outcome. The mayor’s office and conference organizers did not immediately respond to CNBC’s request for comment.

On Tuesday, Florida said it would no longer report daily Covid cases and deaths as vaccinations increase and move into the “next phase” of the pandemic. Florida reported an average of eight new cases per 100,000 residents last week, well below its pandemic high of 84 per 100,000, according to Johns Hopkins University.